Nonfactor Therapies in Hemophilia A: An Essential Drug Entity.

Inequity in the access to effective therapies for rare diseases, such as hemophilia A, is a significant concern in resource-limited settings. Including necessary medications in the essential drug list can ensure that populations have access to safe and affordable treatments. Emicizumab, a nonfactor therapy, addresses many of the challenges associated with traditional factor replacement for hemophilia A, including frequent administration and the risk of inhibitor development.

Role and Function of Frontline Health Workers During the COVID-19 Pandemic in a Rural Health Center in Kerala: A Qualitative Study.

Introduction Accredited Social Health Activists (ASHAs) are community health workers established under the National Rural Health Mission (NRHM). ASHAs have played a crucial role in responding to the COVID-19 pandemic. The COVID-19 pandemic has prompted ASHAs to adapt their strategies and methods to effectively address the challenges and ensure the well-being of the communities they serve.